These are the most overbought and oversold stocks in the S&P 500 as 2026 begins
The year just began, but there may be opportunities for investors to catch potential bounces on some stocks…
Berkshire Hathaway shares dip as Warren Buffett exits and Greg Abel era begins
Warren Buffett and Greg Abel walkthrough the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3,…
The market bubble heading into 2026 may not be AI. It could be this metal
Silver is overbought with the currently rally showing some signs of a bubble, according to Ned Davis Research.…
5 themes that defined business and markets in 2025: Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday and New Year’s…
Dip-buying, ‘TACO’ trade power strong year
A graph displaying the Apple stock price on a smartphone app. Jaap Arriens | Nurphoto | Getty Images…
Bitcoin fell in 2025, but can it rebound in the new year?
Bitcoin boomed earlier this year, but its seemingly magical momentum didn’t last. In the last quarter, the token…
Stock market offered opportunities in 2025, even as some big names stumbled: Josh Brown
The story of the stock market in 2025 is its ability to advance even as big technology names…
Nvidia quietly bought a competitor last week. Why analysts believe this could be big deal
Nvidia has considerable room to run after spending billions of dollars on assets from artificial intelligence accelerator chipmaker…
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
Jim Cramer looks back at 2025’s biggest market themes
As the year comes to an end, CNBC’s Jim Cramer revisited questions he asked at the start of…
We’re putting an AI giant in the Bullpen — not letting a mistake cloud our judgment
Alphabet can no longer be ignored. It is going back into our Bullpen list of stocks to watch…
Wall Street’s top stock picks for 2026: Mizuho’s under-the-radar name
Mizuho’s top stock pick for 2026 is a vaccine maker that has a major leg up over its…